Monday, November 18, 2024

Halozyme says €2 billion takeover of Evotech would create leader in drug discovery

Must read




Halozyme says the combined company would have an estimated $2 billion in revenue in 2025.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article